Ipsen S.A. (EPA:IPN)
France · Delayed Price · Currency is EUR 158.20
+0.90 (0.57%)
At close: Feb 19, 2026
Ipsen Revenue
In the year 2025, Ipsen had annual revenue of 3.93B EUR with 9.92% growth. Ipsen had revenue of 1.99B in the half year ending December 31, 2025.
Revenue
3.93B
Revenue Growth
+9.92%
P/S Ratio
3.29
Revenue / Employee
733.33K
Employees
5,358
Market Cap
12.91B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 3.93B | 354.70M | 9.92% |
| Dec 31, 2024 | 3.57B | 268.10M | 8.11% |
| Dec 31, 2023 | 3.31B | 150.00M | 4.75% |
| Dec 31, 2022 | 3.16B | 407.80M | 14.84% |
| Dec 31, 2021 | 2.75B | 62.40M | 2.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sanofi | 46.72B |
| EssilorLuxottica Société anonyme | 28.49B |
| Eurofins Scientific SE | 7.30B |
| emeis Société anonyme | 5.77B |
| Clariane SE | 5.31B |
| Ramsay Générale de Santé | 5.24B |
| bioMérieux | 4.12B |
| Sartorius Stedim Biotech | 2.95B |
Ipsen News
- 9 hours ago - Ipsen S.A. publishes its 2025 Consolidated Financial Statements - GlobeNewsWire
- 6 days ago - Ipsen SA (IPSEY) Full Year 2025 Earnings Call Highlights: Strong Sales Growth and Strategic ... - GuruFocus
- 7 days ago - Full Year 2025 Ipsen SA Earnings Call Transcript - GuruFocus
- 7 days ago - Ipsen S.A. (IPSEY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Ipsen S.A. 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 7 days ago - Ipsen S.A. Non-GAAP EPS of €12.09, revenue of €3.68B; sets full-year 2026 guidance and mid-term outlook - Seeking Alpha
- 5 weeks ago - Ipsen S.A. (IPSEY) Presents at 44th Annual J.P. Morgan Healthcare Conference - Slideshow - Seeking Alpha
- 5 weeks ago - FDA Boosts Ipsen (IPSEY) with Breakthrough Therapy Designation for AML Treatment - GuruFocus